see attachment Table 1: Standard Levels of hCG During PregnancyTable 2: hCG Trends in Various Pregnancy ScenariosTable 3: Common Complaints

see attachment 

Table 1: Standard Levels of hCG During Pregnancy

Table 2: hCG Trends in Various Pregnancy Scenarios

Table 3: Common Complaints During Pregnancy

GA Weeks (LMP) hCG Level (mIU/mL)

3 weeks LMP 5 – 50

4 weeks LMP 5 – 426

5 weeks LMP 18 – 7,340

6 weeks LMP 1,080 – 56,500

7–8 weeks LMP 7,650 – 229,000

9–12 weeks LMP 25,700 – 288,000

13–16 weeks LMP 13,300 – 254,000

17–24 weeks LMP 4,060 – 165,400

25–40 weeks LMP 3,640 – 117,000

Non-pregnant < 5

Scenario Beta hCG Level Expected to…

Normal ongoing pregnancy Increase by 66% or more in 48–72 hours

Spontaneous abortion
(miscarriage)

Decrease by 21–35% or more in 48–72
hours

Ectopic pregnancy Increase slowly, plateau, or decrease

Gestational trophoblastic
pregnancy Increase excessively/highly elevated

Sympt
om

Definition and
Cause

Presentation &
Possible DDX Treatment Education

Consti
pation

Progesterone
relaxes bowel
muscles; slowed
GI motility

Infrequent, hard
stools; bloating;
DDX: bowel
obstruction,
hypothyroidism

High fiber diet,
hydration,
physical activity;
docusate or
psyllium as
needed

Avoid stimulant
laxatives;
increase water
and fiber intake

Back
Pain

Postural changes,
weight gain,
ligament laxity

Lumbar pain,
worse at end of
day; DDX: UTI,
kidney stones

Heat, stretching,
massage,
acetaminophen

Posture support,
avoid heavy
lifting, supportive
shoes

GERD

Relaxation of LES
due to
progesterone;
enlarged uterus
compresses
stomach

Heartburn, sour
taste; DDX: PUD,
cardiac chest pain

Small meals,
antacids, H2
blockers or PPIs
if needed

Elevate head of
bed, avoid spicy/
fatty foods, don’t
lie flat after
meals

Fatigu
e

Hormonal
changes,
increased energy
demands

General
tiredness; DDX:
anemia,
hypothyroidism,
depression

Rest, naps, iron
supplements if
anemic

Normalize
fatigue;
encourage sleep
and balanced
nutrition

Heart
Palpita
tions

Increased blood
volume and
cardiac output

Sensation of
fluttering; DDX:
arrhythmia,
anemia,
hyperthyroidism

Reassurance,
EKG if abnormal
or symptomatic

Usually benign;
report if
associated with
SOB, dizziness,
or chest pain

Urinar
y
Freque
ncy

Uterine pressure
on bladder,
increased renal
perfusion

Frequent urination
without pain;
DDX: UTI

Rule out infection;
otherwise
reassurance

Void regularly,
stay hydrated,
report burning or
urgency

Nause
a and
Vomiti
ng

hCG and estrogen
effects on GI
system

Typically 1st
trimester; DDX:
gastroenteritis,
hyperemesis
gravidarum

Vitamin B6,
doxylamine, small
bland meals,
antiemetics if
severe

Often resolves
by 2nd trimester;
eat small meals,
avoid triggers

Subjective

• Bleeding began 3 days ago as spotting and has since become light period-like bleeding. It is
ongoing.

• She denies any pain. No specific mention of other symptoms; these should be clarified
during the visit.

• No prior pregnancies, miscarriages, or abortions

• The patient had unprotected intercourse two days prior

• No traumas or strenuous activity

• Denies any nausea, vomiting, breast tenderness, or fatigue 


Other Medical History Questions

• Menstrual history: amenorrhea x2 months with positive pregnancy test. STI and Pap history:
none

• No chronic medical conditions

• No medication/food/environmental allergies

Round
Ligam
ent
Pain

Stretching of
uterine ligaments
as uterus enlarges

Sharp, brief pain
in groin/lower
abdomen; DDX:
appendicitis,
ovarian torsion

Reassurance,
position changes,
acetaminophen

Normal; avoid
sudden
movements; use
warm compress

Hyper
pigme
ntation

Hormonal
stimulation of
melanocytes (e.g.,
melasma, linea
nigra)

Dark patches on
face, abdomen;
DDX: Addison’s
disease

Usually no
treatment needed

Common and
benign; usually
fades postpartum

Sleep
Distur
bance

Hormonal
changes,
discomfort,
anxiety, nocturia

Trouble falling or
staying asleep;
DDX: depression,
restless legs
syndrome

Sleep hygiene,
relaxation
techniques, left
side sleeping

Avoid caffeine,
screens; use
pillows for
support; maintain
sleep schedule

• Vaccinations are up to date for her age, COVID vaccine received (no boosters)

• Mental Health Screening Complete: No risk

Other Social History Questions

• Denies substance use (tobacco, alcohol, drugs

• Social support system: Mother, Father, Partner, Best Friends

• Intimate partner violence screening: Denies

• Senior Year in High-school

• Stable home environment

Objective

a. Head-to-toe assessment:

• Vital Signs:

o Temperature: 98.4°F (36.9°C)

o Heart Rate (HR): 84 beats per minute

o Respiratory Rate (RR): 16 breaths per minute

o Blood Pressure (BP): 110/68 mmHg

o Oxygen Saturation (SpO₂): 98% on room air

o Weight: 132 lbs (59.9 kg)

o BMI: 22 – Normal weight range

• HEENT: Hydration status

• Cardiac/Respiratory: Baseline function

• Abdomen: Palpation for tenderness, guarding, masses

• Pelvic exam:

o External genitalia inspection

o Speculum exam: check for active bleeding, source of bleeding (cervix vs vaginal)

o Bimanual exam: uterine size, adnexal masses/tenderness, cervical motion tenderness

b. Tests and rationale:

• Quantitative beta-hCG: Monitor pregnancy progression or loss (Doubling every 48–72h is
expected in viable pregnancy)

• Transvaginal ultrasound: Confirm intrauterine pregnancy or assess for ectopic (TVUS can
detect gestational sac at hCG ≥1500–2000 mIU/mL)

• CBC: Evaluate for anemia or infection

• Type and screen: Determine Rh status (important if Rh-negative and bleeding)

• STI screening: Chlamydia, gonorrhea, HIV, syphilis, Hep B/C

• Pap smear (if due)

Assessment / Diagnosis

a. Presumptive diagnosis:

• Threatened abortion (vaginal bleeding with closed cervix and viable intrauterine
pregnancy)

Differential diagnoses:

• Early intrauterine pregnancy with normal implantation bleeding

• Ectopic pregnancy

• Spontaneous abortion (inevitable, incomplete, or missed)

• Molar pregnancy (less likely with current hCG levels)

b. Additional differentials:

• Cervical pathology (polyps, ectropion)

• Coagulopathy or bleeding disorder

c. HCG results interpretation:

• Day 1 hCG: 1200 mIU/mL

• Day 3 hCG: 550 mIU/mL → Significant decline (>50%)

Diagnosis:

• Spontaneous abortion (miscarriage) 

This is supported by a falling hCG level, which indicates a nonviable pregnancy.

4. Plan

a. Explaining hCG results:

• “Your hCG level has dropped significantly, which indicates that the pregnancy is no longer
progressing. This means that you are likely having a miscarriage.”

b. Treatment & follow-up:

Options:

1. Expectant management – allow natural passage of tissue.

2. Medical management – misoprostol to induce expulsion.

3. Surgical management – uterine aspiration/D&C if heavy bleeding, infection, or incomplete
passage.

Medications:

• Misoprostol (600–800 mcg vaginally or orally)

o Side effects: cramping, bleeding, nausea, diarrhea

o Success rate: ~80-90% in early pregnancy loss (ACOG, 2018)

Partner notification:

• Not typically required unless STI is suspected.

Follow-up:

• Repeat hCG until <5 mIU/mL

• Monitor for signs of infection or retained products

• Ultrasound if bleeding persists or incomplete passage is suspected

c. Patient education:

• Emotional support: Normalize grief response, provide reassurance

• Sexual activity: Wait until bleeding stops and no signs of infection (usually 1–2 weeks)

• Contraception: Discuss short-term options if not ready to conceive

• Trying to conceive again: Safe to try after 1 normal menstrual cycle; ACOG supports early
attempts if emotionally ready

• Red flags: heavy bleeding, foul-smelling discharge, fever, severe pain → return immediately

  • Table 1: Standard Levels of hCG During Pregnancy
  • Table 2: hCG Trends in Various Pregnancy Scenarios
  • Table 3: Common Complaints During Pregnancy
  • Subjective
    • Other Medical History Questions
    • Other Social History Questions
    • Objective
    • Vital Signs:
    • Assessment / Diagnosis
    • 4. Plan

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  This week’s discussion is a two folds discussion. First, explain the role of the Psychiatric Mental Health Nurse Practitioner as it relates to the

  This week’s discussion is a two folds discussion. First, explain the role of the Psychiatric Mental Health Nurse Practitioner as it relates to the scope of psychotherapy. Second, explain how this week’s discussion aligns with the following APNA standard: Standard 5G: Therapeutic Relationship: Psychiatric-mental health registered nurse uses therapeutic relationship

  This week’s discussion is a two folds discussion. First, explain the role of the Psychiatric Mental Health Nurse Practitioner as it relates to the

  This week’s discussion is a two folds discussion. First, explain the role of the Psychiatric Mental Health Nurse Practitioner as it relates to the scope of psychotherapy. Second, explain how this week’s discussion aligns with the following APNA standard: Standard 5G: Therapeutic Relationship: Psychiatric-mental health registered nurse uses therapeutic relationship

  This week’s discussion is a two folds discussion. First, explain the role of the Psychiatric Mental Health Nurse Practitioner as it relates to the

  This week’s discussion is a two folds discussion. First, explain the role of the Psychiatric Mental Health Nurse Practitioner as it relates to the scope of psychotherapy. Second, explain how this week’s discussion aligns with the following APNA standard: Standard 5G: Therapeutic Relationship: Psychiatric-mental health registered nurse uses therapeutic relationship

#1 An action item that resonated with my role as a clinical nurse coordinator is the ability to enhance quantitative reasoning. It is important to show

#1 An action item that resonated with my role as a clinical nurse coordinator is the ability to enhance quantitative reasoning. It is important to show that “the most successful population health initiatives have demonstrated their effectiveness through distinctive quality improvement methods that combine thinking about assessment, outcomes, and costs